SEC Form D · filed September 24, 2019
Insilico Medicine Cayman TopCo
Offering
$36.8M
Sold
$36.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HONG KONG, Hong Kong
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗